Maaike Roelofs , Kalpana Ramkisoensing , Rixt Even , Huub H. van Rossum
{"title":"凝血管中常规临床生化分析物的预处理稳定性;研究(不)适合家庭样本采集。","authors":"Maaike Roelofs , Kalpana Ramkisoensing , Rixt Even , Huub H. van Rossum","doi":"10.1016/j.cca.2024.120035","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>There is a growing interest in self-collection of blood for clinical applications. Next to allowing patients to self-sample blood, adequate sample stability of the analyte is essential to provide an accurate and reliable test result. This is particularly important for self-collected blood, as the transport of the sample to the clinical laboratory will generally require significantly more time than routine blood samples collected by healthcare professionals, and under less controlled circumstances.</div></div><div><h3>Methods</h3><div>Three additional blood collection tubes (coagulation tubes) were collected from nine patients; one was processed immediately, the second and third were processed after 48 h of storage at 20 °C and 37 °C, respectively. The collected serum was stored at −20 °C and samples collected from individual patients were analyzed in the same analytical run for 18 routine chemistry analytes and the tumor markers PSA and CEA. The recoveries obtained after delayed processing were quantified and the quality of the sample for each analyte was determined using the analytical performance specifications based on biological variation.</div></div><div><h3>Results</h3><div>For each analyte, the quality level of samples with delayed processing was determined. For the CEA, PSA, CRP, creatinine, HDL-cholestrol, triglycerides and yGT the recovery was within the desirable bias requirement. Recovery for glucose, all included electrolytes, ALT and AST exceeded the minimum bias criterion.</div></div><div><h3>Conclusions</h3><div>Several analytes including sodium, chloride, potassium, calcium, and liver enzymes were not, while others; CEA, PSA, CRP, creatinine and triglycerides, were found to be sufficiently stable in coagulated blood, when processed with a delay of 48 h.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"567 ","pages":"Article 120035"},"PeriodicalIF":3.2000,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pre-processing stability of routine clinical chemistry analytes in a clotting tube; investigating the (un)suitability for at-home sample collection\",\"authors\":\"Maaike Roelofs , Kalpana Ramkisoensing , Rixt Even , Huub H. van Rossum\",\"doi\":\"10.1016/j.cca.2024.120035\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>There is a growing interest in self-collection of blood for clinical applications. Next to allowing patients to self-sample blood, adequate sample stability of the analyte is essential to provide an accurate and reliable test result. This is particularly important for self-collected blood, as the transport of the sample to the clinical laboratory will generally require significantly more time than routine blood samples collected by healthcare professionals, and under less controlled circumstances.</div></div><div><h3>Methods</h3><div>Three additional blood collection tubes (coagulation tubes) were collected from nine patients; one was processed immediately, the second and third were processed after 48 h of storage at 20 °C and 37 °C, respectively. The collected serum was stored at −20 °C and samples collected from individual patients were analyzed in the same analytical run for 18 routine chemistry analytes and the tumor markers PSA and CEA. The recoveries obtained after delayed processing were quantified and the quality of the sample for each analyte was determined using the analytical performance specifications based on biological variation.</div></div><div><h3>Results</h3><div>For each analyte, the quality level of samples with delayed processing was determined. For the CEA, PSA, CRP, creatinine, HDL-cholestrol, triglycerides and yGT the recovery was within the desirable bias requirement. Recovery for glucose, all included electrolytes, ALT and AST exceeded the minimum bias criterion.</div></div><div><h3>Conclusions</h3><div>Several analytes including sodium, chloride, potassium, calcium, and liver enzymes were not, while others; CEA, PSA, CRP, creatinine and triglycerides, were found to be sufficiently stable in coagulated blood, when processed with a delay of 48 h.</div></div>\",\"PeriodicalId\":10205,\"journal\":{\"name\":\"Clinica Chimica Acta\",\"volume\":\"567 \",\"pages\":\"Article 120035\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-11-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinica Chimica Acta\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0009898124022885\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898124022885","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
Pre-processing stability of routine clinical chemistry analytes in a clotting tube; investigating the (un)suitability for at-home sample collection
Background
There is a growing interest in self-collection of blood for clinical applications. Next to allowing patients to self-sample blood, adequate sample stability of the analyte is essential to provide an accurate and reliable test result. This is particularly important for self-collected blood, as the transport of the sample to the clinical laboratory will generally require significantly more time than routine blood samples collected by healthcare professionals, and under less controlled circumstances.
Methods
Three additional blood collection tubes (coagulation tubes) were collected from nine patients; one was processed immediately, the second and third were processed after 48 h of storage at 20 °C and 37 °C, respectively. The collected serum was stored at −20 °C and samples collected from individual patients were analyzed in the same analytical run for 18 routine chemistry analytes and the tumor markers PSA and CEA. The recoveries obtained after delayed processing were quantified and the quality of the sample for each analyte was determined using the analytical performance specifications based on biological variation.
Results
For each analyte, the quality level of samples with delayed processing was determined. For the CEA, PSA, CRP, creatinine, HDL-cholestrol, triglycerides and yGT the recovery was within the desirable bias requirement. Recovery for glucose, all included electrolytes, ALT and AST exceeded the minimum bias criterion.
Conclusions
Several analytes including sodium, chloride, potassium, calcium, and liver enzymes were not, while others; CEA, PSA, CRP, creatinine and triglycerides, were found to be sufficiently stable in coagulated blood, when processed with a delay of 48 h.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.